An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment. - Gelderblom, H; Perol, D; Chevreau, C; Tattersall, M; Stacchiotti, S; Casali, P; Cropet, C; Piperno-Neumann, S; Le Cesne, A; Italiano, A; Ferraresi, V; Duffaud, F; et al. (JOURNAL OF CLINICAL ONCOLOGY, 2013)